Literature DB >> 18172943

[Resistance and refractoriness in obsessive-compulsive disorder].

Ygor Arzeno Ferrão1, Juliana Belo Diniz, Antônio Carlos Lopes, Roseli Gedanke Shavitt, Benjamin Greenberg, Euripedes Miguel.   

Abstract

OBJECTIVE AND
METHOD: Despite the existence of effective therapeutic alternatives for obsessive-compulsive disorder, a significant number of patients does not achieve or does not maintain remission after adequate treatment. The relief of these patients' suffering with the available treatments is a clinical challenge related to many unanswered questions. The objective of this literature review is to evaluate the current concepts of treatment resistance and refractoriness, to describe the intrinsic and extrinsic factors of obsessive-compulsive disorder's phenomenology that might influence treatment response to conventional treatment, and to present a fluxogram of therapeutic alternatives for resistant or refractory obsessive compulsive disorder patients.
CONCLUSION: The literature evinces that intrinsic and/or extrinsic phenomenological aspects of obsessive-compulsive disorder may collaborate to the fact that, at least 30% of obsessive-compulsive disorder patients do not respond to conventional treatment. Several therapeutic or augmentation alternatives, psychopharmacological, biological or even psychotherapeutical exist, but more studies are necessary to evince the correct way to symptom remission.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18172943     DOI: 10.1590/s1516-44462006005000059

Source DB:  PubMed          Journal:  Braz J Psychiatry        ISSN: 1516-4446            Impact factor:   2.697


  3 in total

Review 1.  Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?

Authors:  Katharine A Phillips; Dan J Stein; Scott L Rauch; Eric Hollander; Brian A Fallon; Arthur Barsky; Naomi Fineberg; David Mataix-Cols; Ygor Arzeno Ferrão; Sanjaya Saxena; Sabine Wilhelm; Megan M Kelly; Lee Anna Clark; Anthony Pinto; O Joseph Bienvenu; Joanne Farrow; James Leckman
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

Review 2.  Deep brain stimulation (DBS) at the interface of neurology and psychiatry.

Authors:  Nolan R Williams; Michael S Okun
Journal:  J Clin Invest       Date:  2013-11-01       Impact factor: 14.808

3.  Risk factors for early treatment discontinuation in patients with obsessive-compulsive disorder.

Authors:  Juliana Belo Diniz; Dante Marino Malavazzi; Victor Fossaluza; Cristina Belotto-Silva; Sonia Borcato; Izabel Pimentel; Euripedes Constantino Miguel; Roseli Gedanke Shavitt
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.